Meyka Pro banner
NEXGEL, Inc.

NEXGEL, Inc. (NXGL) Stock Overview

Explore NEXGEL, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NXGLNASDAQ
HealthcareMedical - Instruments & Supplies
$0.44
$0.009(2.09%)
U.S. Market opens in 14h 26m

NEXGEL, Inc. (NXGL)

Meyka AI Score

Z

Key Financials

Market Cap4M
P/E Ratio-1.15
EPS (TTM)$-0.39
ROE-0.70%
Fundamental Analysis

AI Price Forecasts

1 Month$0.49
3 Months$0.24
1 Year Target$0.07

NXGL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of NEXGEL, Inc. (NASDAQ: NXGL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, NEXGEL, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NXGL on the NASDAQ shows an RSI of 42.20, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.07 for the NASDAQ listing.

Key metrics behind NEXGEL, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.15 and a market capitalization of 4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NXGL on the NASDAQ.

Price Performance (NASDAQ: NXGL)

1-Day Change
2.09%
5-Day Change
N/A
1-Month Change
-18.72%
3-Month Change
-32.04%
6-Month Change
-73.71%
Year-to-Date (YTD) Change
-72.73%
1-Year Change
-81.55%
3-Year Change
-79.95%
5-Year Change
-87.53%
All-Time (Max) Change
-87.53%

Contact Information

215 702 8550
2150 Cabot Boulevard West, Langhorne, PA, 19047

Company Facts

190 Employees
IPO DateDec 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions